XML 41 R25.htm IDEA: XBRL DOCUMENT v3.3.0.814
Quarterly Statement of Operations Information (Unaudited)
12 Months Ended
Sep. 26, 2015
Quarterly Financial Information Disclosure [Abstract]  
Quarterly Statement of Operations Information (Unaudited)
Quarterly Statement of Operations Information (Unaudited)
The following table presents a summary of quarterly results of operations for fiscal 2015 and 2014:
 
 
 
2015
First
Quarter
 
Second
Quarter
 
Third
Quarter
 
Fourth
Quarter
Total revenue
 
$
652.8

 
$
655.5

 
$
693.9

 
$
702.8

Gross profit
 
338.6

 
336.0

 
378.7

 
379.4

Net income (1)
 
29.2

 
47.8

 
29.4

 
25.2

Diluted net income per common share
 
$
0.10

 
$
0.17

 
$
0.10

 
$
0.09

 
 
 
2014
First
Quarter
 
Second
Quarter
 
Third
Quarter
 
Fourth
Quarter
Total revenue
 
$
612.4

 
$
625.0

 
$
632.6

 
$
660.6

Gross profit
 
305.6

 
282.1

 
312.8

 
345.0

Net income (loss) (2)
 
(5.4
)
 
(16.8
)
 
11.3

 
28.2

Diluted net income (loss) per common share
 
$
(0.02
)
 
$
(0.06
)
 
$
0.04

 
$
0.10

 
(1)
Net income in the first quarter of fiscal 2015 included restructuring charges of $8.0 million and a debt extinguishment loss of $6.7 million. Net income in the third quarter of fiscal 2015 included restructuring and divestiture charges of $11.9 million and a debt extinguishment loss of $18.2 million. Net income in the fourth quarter of fiscal 2015 included restructuring charges of $6.5 million, a debt extinguishment loss of $37.8 million, and an other-than-temporary impairment charge of $7.8 million related to a marketable security.

(2)
Net loss in the first quarter of fiscal 2014 included restructuring charges of $18.4 million and a debt extinguishment loss of $2.9 million. Net loss in the second quarter of fiscal 2014 included an impairment charge related to the MRI breast coils product line of $28.6 million, restructuring charges of $11.6 million and a debt extinguishment loss of $4.4 million. Net income in the third quarter of fiscal 2014 included restructuring charges of $6.7 million. Net income in the fourth quarter of fiscal 2014 included restructuring and divestiture charges of $15.1 million and a $5.1 million IPR&D charge.